Matthew Miskell

Matthew Miskell currently serves as a Junior Analyst in Chemistry at Vitex Pharmaceuticals, Australia's premier contract manufacturing facility specializing in tablets and capsules. In this role, Matthew leverages his multidisciplinary background to support the company's commitment to quality, innovation, and operational excellence. His expertise in analytical methods development and high-performance liquid chromatography (HPLC) plays a crucial role in ensuring the integrity and consistency of the products manufactured at Vitex. By meticulously conducting lab tests aligned with Good Laboratory Practice (GLP) standards, Matthew helps maintain rigorous quality control across the production process, from raw material testing to final product release.

A key focus of Matthew’s work involves supporting the scaling of formulations from pilot batches to full-scale manufacturing, ensuring seamless transition while maintaining product efficacy and safety. His proficiency in FTIR spectroscopy and other analytical techniques enables rapid troubleshooting and process optimization, which is vital in a fast-moving consumer goods (FMCG) environment. Additionally, Matthew collaborates closely with product development teams to refine formulations and improve manufacturing efficiencies, contributing to Vitex’s ability to meet increasing demand and uphold its reputation for excellence.

Beyond technical expertise, Matthew’s role involves coordinating with cross-functional teams to streamline scheduling and supply chain logistics, ensuring timely delivery of high-quality products to leading brands both domestically and internationally. His passion for complementary medicines and comprehensive understanding of the “concept to shelf” process make him a valuable asset in driving innovation and maintaining Vitex’s position at the forefront of contract manufacturing in Australia.